Using Hypnotherapy For Dementia & Alzheimer's
NCT01435551 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2016-02-04
Summary
From the past research that has been done the investigators have learned that brain cells die \& leave a deposit in the brain known as beta-amyloid. Since alzheimer's is a slow acting disease the natural immune system does not respond to this illness so this builds up in the brain. As it builds up it gets into the neurotransmitters in the brain causing more brain cells to die. As these buildups occur dementia sets in due to more of the brain dying \& effects normal activity.
STUDY WAS CANCELLED
Hypnotherapy will be used to do the following things:
* Increase the immune system
* The immune system will begin to clean up the beta-amyloid buildup
* That removes damage cells of the brain
* Increase more blood flow to the brain
* Allows the active brain cells to be trained to carry out daily activities
STUDY WAS CANCELLED
Conditions
- Alzheimer Disease
Interventions
- OTHER
-
Hypnotherapy
1 year study,1 hour session per month for 9 months, 3 remaining months evaluation
Sponsors & Collaborators
-
Families To The Rescue
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
NCT01195389 ·Status: UNKNOWN ·Phase: NA
-
Hyperbaric Oxygen Therapy for Prodromal Alzheimer´s Disease With Cerebrovascular Disease
NCT05349318 ·Status: RECRUITING ·Phase: NA
-
Deep Brain Stimulation for Alzheimer's Disease
NCT03959124 ·Status: UNKNOWN ·Phase: NA
-
Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET
NCT01202994 ·Status: COMPLETED ·Phase: PHASE2
-
Zolpidem CR and Hospitalized Patients With Dementia
NCT00814502 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography (PET) Amyloid Imaging of the Brain in Healthy Young Adult Subjects
NCT01265394 ·Status: COMPLETED ·Phase: PHASE3
-
Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease
NCT01227564 ·Status: COMPLETED ·Phase: PHASE2
-
Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease
NCT03089827 ·Status: ENROLLING_BY_INVITATION
-
Clinical Trial on Agitation in Alzheimer's Dementia
NCT05543681 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of Nabilone in Alzheimer's Disease
NCT02351882 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
NCT01028053 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease
NCT03522129 ·Status: COMPLETED ·Phase: PHASE1
-
Deep Brain Stimulation for Treatment of Severe Alzheimer's Disease
NCT03115814 ·Status: UNKNOWN
-
Applying PET/MR for Dementia Applications
NCT04154254 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease
NCT01492374 ·Status: COMPLETED ·Phase: PHASE1
-
Pain Perception in Alzheimer's Disease
NCT00192816 ·Status: UNKNOWN
-
Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for Alzheimer's Disease
NCT00939822 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's Disease
NCT02305836 ·Status: UNKNOWN ·Phase: PHASE2
-
A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment
NCT05040217 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease
NCT00704782 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
NCT06651567 ·Status: RECRUITING ·Phase: PHASE2
-
Endothelial Facilitation in Alzheimer's Disease
NCT01439555 ·Status: COMPLETED ·Phase: PHASE2
-
CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
NCT02021682 ·Status: COMPLETED
-
Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
NCT02600130 ·Status: COMPLETED ·Phase: PHASE1
-
Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET Examination
NCT04305210 ·Status: UNKNOWN ·Phase: PHASE2